This study is being done to collect cancer-related information from patients with triple negative breast cancer and patients with hereditary genetic mutations. This information will help us better understand the link between genetic changes and cancer outcome in patients with triple negative breast cancer.
Age
Any age
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Triple Negative Breast Cancer
ER/PR \<10% and HER negative per current ASCO/CAP guidelines
Stages I-IV
Any age at diagnosis
Patient must be within 5 years of diagnosis
Eligible regardless of genetic testing status
Genetic testing recommended for patients meeting NCCN and Medicare guidelines
AND/OR
Germline mutation Carriers
Patients with deleterious or uncertain mutations in HBOC genes (BRCA, PTEN, P53, -PALB2 etc) are eligible regardless of type/site of cancer
Healthy patients harboring mutations also eligible
There is no time limit from the time of diagnosis of cancer and enrollment.
Eligible regardless of personal history of cancer
You may not be if
Triple Negative Breast Cancer -Patient is not within five years of diagnosis
Germline mutation Carriers:
Patient only carries a HBOC mutation that is classified as "polymorphism" of "favor polymorphism"
Clareo Health | Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
